The platelet aggregation devices market size is expected to see exponential growth in the next few years. It will grow to $2.07 billion in 2028 at a compound annual growth rate (CAGR) of 25.5%. The growth in the forecast period can be attributed to growing aging population, rising demand for point-of-care testing, expansion of personalized medicine, regulatory support and approvals, increasing prevalence of chronic diseases. Major trends in the forecast period include integration of artificial intelligence in diagnostics, development of portable platelet aggregation devices, increased collaboration between biotech firms and healthcare providers, rising importance of data analytics in healthcare, shift towards home-based diagnostics.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/platelet-aggregation-devices-global-market-report
Scope Of Platelet Aggregation Devices Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Platelet Aggregation Devices Market Overview
Market Drivers –
The increasing incidence of target diseases is expected to drive the platelet aggregation devices market going forward. Target diseases are specific medical conditions that are the focus of prevention, diagnosis, and treatment efforts due to their significant impact on public health, such as cancer, cardiovascular diseases, and diabetes. Platelet aggregation devices help in decreasing the incidence of target diseases by enabling early detection and effective management of thrombotic risks, thereby preventing complications like heart attacks and strokes in vulnerable populations. For instance, in February 2024, according to statistics published by the International Agency for Research on Cancer (IARC), a France-based specialized cancer agency of the World Health Organization (WHO), the world saw approximately 20 million new cancer cases and 9.7 million deaths in 2022, with projections indicating a 77% increase to over 35 million new cases by 2050; lung cancer was the most prevalent globally with 2.5 million new cases (12.4%), followed by female breast cancer (2.3 million cases, 11.6%), colorectal cancer (1.9 million cases, 9.6%), prostate cancer (1.5 million, 7.3%), and stomach cancer (970,000, 4.9%). Therefore, the increasing incidence of target diseases is driving the growth of the platelet aggregation devices market.
Market Trends –
Major companies operating in the platelet aggregation devices market are increasing their focus on developing advanced solutions by launching innovative products such as the first platelet pooling set to help stabilize the U.S. platelet supply and meet growing needs. A platelet pooling set is a specialized medical device used during plateletpheresis procedures to collect and concentrate platelets from multiple donors into a single unit for transfusion therapy. For instance, in February 2023, TERUMO BCT INC., a US-based company providing blood components and cellular technology, announced the approval of the IMUGARD WB Platelet Pooling Set by the Food and Drug Administration (FDA), a US-based federal agency. This offers extended shelf life for platelets, FDA clearance for seven-day storage, and enables platelet recoupment from whole blood donations, enhancing flexibility and availability in the platelet aggregation devices market. This launch represents a significant technological advancement by addressing the need for improved platelet availability, more efficient supply management, and supporting strained U.S. platelet supply to meet increasing demand in critical medical procedures like chemotherapy and organ transplants.
The platelet aggregation devices market covered in this report is segmented –
1) By Product: Reagents, Systems, Consumables And Accessories
2) By Type: Four Channel, Dual Channel, Eight Channel
3) By Technology: Optical, Impedance, Other Technologies
4) By Application: Clinical Applications, Research Applications, Cardiovascular Applications, Orthopedic Applications, Other Applications
5) By End-User: Standalone Hospitals, Diagnostic Laboratories, Research And Academic Institutes, Other End Users
Get an inside scoop of the platelet aggregation devices market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=15896&type=smp
Regional Insights –
North America was the largest region in the platelet aggregation devices market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the platelet aggregation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the platelet aggregation devices market are Roche Holding AG, Cytiva (Danaher Corp.), Siemens Healthineers, Sysmex Corporation, WerfenLife S.A., Haemonetics Corporation, Helena Laboratories Corporation, Sarstedt AG & Co. KG, Sekisui Diagnostics LLC, Diagnostica Stago, Accriva Diagnostics Holdings Inc., Drucker Diagnostics, Sentinel CH. SpA, ADInstruments, Chrono-Log Corporation, Bio/Data Corporation, Haemochrom Diagnostica GmbH, AggreDyne Inc., Hart Biologicals Ltd., Stago
Table of Contents
1. Executive Summary
2. Platelet Aggregation Devices Market Report Structure
3. Platelet Aggregation Devices Market Trends And Strategies
4. Platelet Aggregation Devices Market – Macro Economic Scenario
5. Platelet Aggregation Devices Market Size And Growth
…..
27. Platelet Aggregation Devices Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Read Related Topics:
https://goodprnews.com/influenza-treatment-market-size/
https://goodprnews.com/lipid-regulators-market-size/
https://goodprnews.com/multi-cancer-early-detection-market-size/
https://topprnews.com/influenza-treatment-market-share/
https://topprnews.com/lipid-regulators-market-share/
https://topprnews.com/multi-cancer-early-detection-market-share/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
